333 W. SANTA CLARA STREET, SUITE 900, SAN JOSE, CA
Other Events
Amended material disclosure
Reports Record Second Quarter 2026 Results, Driven by Accelerating Commercial Adoption and 61% Sequential Quarterly Revenue Growth
To Highlight TAMP™ Platform at JonesTrading Virtual Key Opinion Leader Webinar on the Evolving Pancreatic Cancer Landscape
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Reports Record First Quarter 2026: Increasing Revenue by 136% Quarter-over-Quarter
Earnings Release
Ramtin Agah Appointed Executive Chairman of RenovoRx, Inc.
Q2
Amended Annual Report
Q1
FY 2025
Q3
FY 2024
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Initial Statement of Beneficial Ownership
Submission Upload
Correspondence